- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 415
Mosa Meat starts cooking up series B
Bell Food Group and M Ventures have contributed to an initial $55m series B tranche for the cultured meat developer spun out of Maastricht University.
Sep 30, 2020Mosa Meat starts cooking up series B
Bell Food Group and M Ventures have contributed to an initial $55m series B tranche for the cultured meat developer spun out of Maastricht University.
Sep 30, 2020UpShow entertains $14m series A
4490 Ventures, a VC firm aligned to University of Wisconsin-Madison, backed a series A extension intended to advance in-venue digital marketing technology company UpShow's product and recruitment plans.
Sep 30, 2020New Ruipeng picks up funding
Tencent has led a round worth hundreds of millions of dollars for New Ruipeng, which is now valued at $4.4bn and also backed by Boehringer Ingelheim and Country Garden.
Sep 29, 2020Palladio fills palette with $20m
Roche has injected funding into Palladio, creators of a drug for autosomal dominant polycystic kidney disease.
Sep 29, 2020Palladio fills palette with $20m
OUP has injected follow-on funding into Palladio, creators of a drug for autosomal dominant polycystic kidney disease.
Sep 29, 2020XtalPi calculates $319m series C
SoftBank Vision Fund 2, PICC Group and Morningside Venture Capital co-led the round, which also attracted Tencent, China Life Insurance, SIG China and others.
Sep 28, 2020Investors deliver $300m to Rappi
Delivery Hero and SoftBank-backed Rappi has picked up more than $300m from a group of investors including T. Rowe Price Associates.
Sep 28, 2020Tencent helps transfer $176m to Taimei
Tencent joined GL Ventures and YF Capital to co-lead a $176m funding round for Taimei Technology, while SoftBank China Venture Capital also invested.
Sep 28, 2020InventisBio ignites $147m series D
Lilly Asia Ventures has returned for a $147m series D round that will allow InventisBio to advance its treatments for breast cancer and gout into phase 2 clinical trials.
Sep 28, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


